Insider Trading activities of Fibrogen Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Fibrogen Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Fibrogen Inc since year 2005. Table 2 shows the detailed insider transactions of Fibrogen Inc since 2005. The reporting company's ticker symbol is FGEN. The reporting company's CIK number is 921299.
The total value of stock buying since 2005 is $163,450.
The total value of stock sales since 2005 is $128,631,537.
The total value of stock option exercises since 2005 is $13,075,211.


 1   2   3 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Fibrogen Inc (FGEN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-06 0 $0 70,151 $3,945,676 44,403 $457,996
2018-05 0 $0 105,259 $5,291,580 67,267 $564,266
2018-04 0 $0 97,772 $4,616,408 85,830 $302,978
2018-03 0 $0 235,083 $12,557,203 121,762 $1,527,383
2018-02 0 $0 115,636 $6,481,130 89,030 $1,273,917
2018-01 0 $0 170,908 $8,920,366 32,000 $477,175
2017-12 3,500 $163,450 141,610 $6,388,091 98,000 $318,840
2017-11 0 $0 72,136 $3,411,964 56,407 $153,680
2017-10 0 $0 172,908 $9,607,749 45,000 $655,875
2017-09 0 $0 115,974 $6,034,632 6,000 $21,600
2017-08 0 $0 224,982 $10,362,075 195,770 $1,650,714
2017-07 0 $0 88,272 $3,013,165 79,600 $189,260
2017-06 0 $0 142,384 $4,250,121 124,889 $547,109
2017-05 0 $0 84,272 $2,271,714 85,600 $206,660
2017-04 0 $0 129,408 $3,299,174 124,900 $528,763
2017-03 0 $0 99,474 $2,490,116 66,016 $254,825
2017-02 0 $0 78,434 $1,860,681 65,982 $265,576
2017-01 0 $0 89,096 $2,106,340 62,864 $242,139
2016-12 0 $0 100,284 $2,113,616 81,206 $326,853
2016-11 0 $0 112,495 $2,425,735 94,798 $383,001
2016-10 0 $0 94,495 $1,764,976 70,455 $283,580
2016-09 0 $0 80,286 $1,622,780 56,364 $226,864
2016-08 0 $0 37,798 $675,922 28,182 $113,432
2016-07 0 $0 64,798 $1,167,390 28,182 $113,432
2016-06 0 $0 85,140 $1,464,101 0 $0
2016-05 0 $0 66,214 $1,176,503 0 $0
2016-04 0 $0 64,750 $1,339,277 10,750 $42,193
2016-03 0 $0 64,750 $1,224,376 58,750 $167,417
2016-02 0 $0 54,000 $938,857 14,127 $60,130
2016-01 0 $0 55,572 $1,206,035 14,000 $40,600
2015-12 0 $0 104,116 $3,146,322 112,300 $771,373
2015-11 0 $0 64,800 $1,792,757 25,000 $69,750
2015-10 0 $0 118,800 $2,683,808 20,000 $47,000
2015-09 0 $0 144,286 $3,877,049 57,406 $144,329
2015-08 0 $0 37,000 $871,321 40,938 $116,304
2015-07 0 $0 68,262 $1,594,828 42,776 $101,293
2015-06 0 $0 27,000 $637,699 30,938 $79,304
2015-05 0 $0 0 $0 26,000 $349,600

Table 2. Detailed insider stock purchases, sales, and option exercises of Fibrogen Inc insiders (FGEN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-06-18 Kurkijarvi Kalevi (Director) Sale 4,000 58.19 232,760
2018-06-18 Kurkijarvi Kalevi (Director) Option Ex 4,000 2.90 11,600
2018-06-14 Cotroneo Pat (SVP, Finance and CFO) Sale 7,750 60.00 465,000
2018-06-14 Cotroneo Pat (SVP, Finance and CFO) Option Ex 7,750 25.40 196,850
2018-06-14 Yu K Peony (Chief Medical Officer) Sale 3,422 59.20 202,582
2018-06-13 Cotroneo Pat (SVP, Finance and CFO) Sale 2,319 57.70 133,806
2018-06-11 Routti Jorma (Director) Sale 6,000 57.48 344,880
2018-06-11 Routti Jorma (Director) Option Ex 6,000 9.78 58,650
2018-06-08 Cotroneo Pat (SVP, Finance and CFO) Sale 1,011 55.55 56,161
2018-06-05 Neff Thomas B (Chief Executive Officer) Sale 19,818 55.15 1,093,022
2018-06-05 Neff Thomas B (Chief Executive Officer) Option Ex 10,320 3.60 37,152
2018-06-04 Neff Thomas B (Chief Executive Officer) Sale 19,818 54.79 1,085,788
2018-06-04 Neff Thomas B (Chief Executive Officer) Option Ex 10,320 3.60 37,152
2018-06-04 Cotroneo Pat (SVP, Finance and CFO) Sale 6,013 55.16 331,677
2018-06-04 Cotroneo Pat (SVP, Finance and CFO) Option Ex 6,013 19.39 116,592
2018-05-21 Cotroneo Pat (SVP, Finance and CFO) Sale 14,987 55.04 824,884
2018-05-21 Cotroneo Pat (SVP, Finance and CFO) Option Ex 14,987 22.39 335,633
2018-05-17 Neff Thomas B (Chief Executive Officer) Sale 19,818 51.83 1,027,226
2018-05-17 Neff Thomas B (Chief Executive Officer) Option Ex 10,320 3.60 37,152
2018-05-17 Kurkijarvi Kalevi (Director) Sale 4,000 51.83 207,320
2018-05-17 Kurkijarvi Kalevi (Director) Option Ex 4,000 2.90 11,600
2018-05-17 Rosenkranz Roberto Pedro (Director) Sale 1,000 52.20 52,200
2018-05-17 Rosenkranz Roberto Pedro (Director) Option Ex 1,000 9.78 9,775
2018-05-16 Neff Thomas B (Chief Executive Officer) Sale 19,818 52.01 1,030,793
2018-05-16 Neff Thomas B (Chief Executive Officer) Option Ex 10,320 3.60 37,152
2018-05-09 Routti Jorma (Director) Sale 6,000 47.10 282,600
2018-05-09 Routti Jorma (Director) Option Ex 6,000 9.78 58,650
2018-05-03 Neff Thomas B (Chief Executive Officer) Sale 19,818 46.86 928,671
2018-05-03 Neff Thomas B (Chief Executive Officer) Option Ex 10,320 3.60 37,152
2018-05-02 Neff Thomas B (Chief Executive Officer) Sale 19,818 47.33 937,886
2018-05-02 Neff Thomas B (Chief Executive Officer) Option Ex 10,320 3.60 37,152
2018-04-23 Cotroneo Pat (VP, Finance and CFO) Option Ex 33,550 2.90 97,295
2018-04-19 Kurkijarvi Kalevi (Director) Sale 4,000 47.69 190,760
2018-04-19 Kurkijarvi Kalevi (Director) Option Ex 4,000 2.90 11,600
2018-04-19 Rosenkranz Roberto Pedro (Director) Sale 1,000 47.70 47,700
2018-04-19 Rosenkranz Roberto Pedro (Director) Option Ex 1,000 9.78 9,775
2018-04-18 Neff Thomas B (Chief Executive Officer) Sale 19,818 48.83 967,772
2018-04-18 Neff Thomas B (Chief Executive Officer) Option Ex 10,320 3.60 37,152
2018-04-17 Neff Thomas B (Chief Executive Officer) Sale 19,818 48.36 958,339
2018-04-17 Neff Thomas B (Chief Executive Officer) Option Ex 10,320 3.60 37,152
2018-04-16 Yu K Peony (Chief Medical Officer) Sale 7,500 47.85 358,875
2018-04-09 Routti Jorma (Director) Sale 6,000 46.35 278,130
2018-04-09 Routti Jorma (Director) Option Ex 6,000 5.95 35,700
2018-04-05 Neff Thomas B (Chief Executive Officer) Sale 19,818 45.62 904,156
2018-04-05 Neff Thomas B (Chief Executive Officer) Option Ex 10,320 3.60 37,152
2018-04-04 Neff Thomas B (Chief Executive Officer) Sale 19,818 45.95 910,676
2018-04-04 Neff Thomas B (Chief Executive Officer) Option Ex 10,320 3.60 37,152
2018-03-21 Neff Thomas B (Chief Executive Officer) Sale 19,818 51.31 1,016,861
2018-03-21 Neff Thomas B (Chief Executive Officer) Option Ex 9,042 3.60 32,551
2018-03-20 Neff Thomas B (Chief Executive Officer) Sale 19,818 50.79 1,006,556
2018-03-20 Neff Thomas B (Chief Executive Officer) Option Ex 9,042 3.60 32,551
2018-03-15 Cotroneo Pat (VP, Finance and CFO) Sale 36,094 52.66 1,900,529
2018-03-15 Cotroneo Pat (VP, Finance and CFO) Option Ex 36,094 24.52 885,205
2018-03-15 Kurkijarvi Kalevi (Director) Sale 4,000 52.63 210,520
2018-03-15 Kurkijarvi Kalevi (Director) Option Ex 4,000 2.90 11,600
2018-03-15 Rosenkranz Roberto Pedro (Director) Sale 1,000 52.47 52,465
2018-03-15 Rosenkranz Roberto Pedro (Director) Option Ex 1,000 9.78 9,775
2018-03-14 Yu K Peony (Chief Medical Officer) Sale 9,891 53.20 526,201
2018-03-13 Cotroneo Pat (VP, Finance and CFO) Sale 5,932 54.61 323,946
2018-03-13 Tamura Toshinari (Director) Sale 24,000 53.40 1,281,480
2018-03-13 Tamura Toshinari (Director) Option Ex 24,000 18.17 436,080
2018-03-13 Riggs Rory B (Director) Sale 12,402 54.39 674,507
2018-03-12 Kearns Thomas F Jr (Director) Sale 18,000 55.00 990,000
2018-03-12 Kearns Thomas F Jr (Director) Option Ex 18,000 3.60 64,800
2018-03-12 Riggs Rory B (Director) Sale 19,693 54.98 1,082,721
2018-03-09 Riggs Rory B (Director) Sale 22,905 55.75 1,276,953
2018-03-08 Neff Thomas B (Chief Executive Officer) Sale 19,818 53.28 1,055,942
2018-03-08 Neff Thomas B (Chief Executive Officer) Option Ex 10,319 2.98 30,699
2018-03-08 Cotroneo Pat (VP, Finance and CFO) Sale 1,894 53.53 101,391
2018-03-07 Neff Thomas B (Chief Executive Officer) Sale 19,818 53.34 1,057,131
2018-03-07 Neff Thomas B (Chief Executive Officer) Option Ex 10,265 2.35 24,122
2018-02-23 Neff Thomas B (Chief Executive Officer) Sale 19,818 56.62 1,122,055
2018-02-23 Neff Thomas B (Chief Executive Officer) Option Ex 10,265 2.35 24,122
2018-02-22 Neff Thomas B (Chief Executive Officer) Sale 19,818 57.23 1,134,283
2018-02-22 Neff Thomas B (Chief Executive Officer) Option Ex 10,265 2.35 24,122
2018-02-16 Cotroneo Pat (VP, Finance and CFO) Sale 3,960 56.48 223,660
2018-02-16 Cotroneo Pat (VP, Finance and CFO) Option Ex 3,960 18.00 71,280
2018-02-15 Cotroneo Pat (VP, Finance and CFO) Sale 45,540 55.77 2,539,765
2018-02-15 Cotroneo Pat (VP, Finance and CFO) Option Ex 45,540 23.83 1,085,218
2018-02-15 Kurkijarvi Kalevi (Director) Sale 6,000 55.91 335,430
2018-02-15 Kurkijarvi Kalevi (Director) Option Ex 6,000 2.90 17,400
2018-02-15 Rosenkranz Roberto Pedro (Director) Sale 1,000 56.01 56,010
2018-02-15 Rosenkranz Roberto Pedro (Director) Option Ex 1,000 9.78 9,775
2018-02-15 Routti Jorma (Director) Sale 6,000 55.91 335,460
2018-02-15 Routti Jorma (Director) Option Ex 6,000 3.50 21,000
2018-02-14 Routti Jorma (Director) Sale 6,000 54.63 327,780
2018-02-14 Routti Jorma (Director) Option Ex 6,000 3.50 21,000
2018-02-08 Yu K Peony (Chief Medical Officer) Sale 7,500 54.23 406,687
2018-01-30 Neff Thomas B (Chief Executive Officer) Sale 19,318 61.53 1,188,636
2018-01-29 Neff Thomas B (Chief Executive Officer) Sale 19,318 61.25 1,183,227
2018-01-29 Yu K Peony (Chief Medical Officer) Sale 10,000 62.00 620,000
2018-01-26 Rosenkranz Roberto Pedro (Director) Sale 6,000 60.00 360,000
2018-01-23 Rosenkranz Roberto Pedro (Director) Sale 1,929 50.00 96,450
2018-01-22 Cotroneo Pat (VP, Finance and CFO) Sale 25,000 48.70 1,217,375
2018-01-22 Cotroneo Pat (VP, Finance and CFO) Option Ex 25,000 18.00 450,000
2018-01-22 Rosenkranz Roberto Pedro (Director) Sale 71 50.00 3,550
2018-01-19 Neff Thomas B (Chief Executive Officer) Sale 19,318 47.32 914,185
2018-01-18 Neff Thomas B (Chief Executive Officer) Sale 19,318 47.66 920,753
2018-01-18 Kurkijarvi Kalevi (Director) Sale 6,000 47.65 285,900
2018-01-18 Kurkijarvi Kalevi (Director) Option Ex 6,000 2.90 17,400
2018-01-18 Rosenkranz Roberto Pedro (Director) Sale 6,000 47.73 286,368
2018-01-18 Rosenkranz Roberto Pedro (Director) Option Ex 1,000 9.78 9,775
2018-01-05 Neff Thomas B (Chief Executive Officer) Sale 19,318 46.56 899,504
2018-01-04 Neff Thomas B (Chief Executive Officer) Sale 19,318 48.89 944,418
2017-12-29 Neff Thomas B (Chief Executive Officer) Sale 19,318 48.43 935,628
2017-12-28 Neff Thomas B (Chief Executive Officer) Sale 19,318 48.43 935,628
2017-12-21 Neff Thomas B (Chief Executive Officer) Sale 19,318 45.22 873,559
2017-12-21 Neff Thomas B (Chief Executive Officer) Option Ex 80,000 3.33 266,640
2017-12-20 Neff Thomas B (Chief Executive Officer) Sale 19,318 43.90 848,002
2017-12-18 Kurkijarvi Kalevi (Director) Sale 2,000 42.80 85,600
2017-12-15 Neff Thomas B (Chief Executive Officer) Sale 19,318 41.93 809,965
2017-12-14 Neff Thomas B (Chief Executive Officer) Sale 19,318 42.79 826,655
2017-12-14 Yu K Peony (Chief Medical Officer) Sale 2,851 43.70 124,588
2017-12-12 Kurkijarvi Kalevi (Director) Sale 12,000 44.45 533,400
2017-12-12 Kurkijarvi Kalevi (Director) Option Ex 12,000 2.90 34,800
2017-12-11 Cotroneo Pat (VP, Finance and CFO) Sale 2,851 46.00 131,146
2017-12-04 Lema Gerald (Director) Buy 3,500 46.70 163,450
2017-12-01 Routti Jorma (Director) Sale 6,000 47.32 283,920
2017-12-01 Routti Jorma (Director) Option Ex 6,000 2.90 17,400
2017-11-30 Routti Jorma (Director) Sale 6,000 47.18 283,080
2017-11-30 Routti Jorma (Director) Option Ex 6,000 2.90 17,400
2017-11-17 Neff Thomas B (Chief Executive Officer) Sale 19,318 46.78 903,638
2017-11-17 Kurkijarvi Kalevi (Director) Sale 2,000 46.65 93,300
2017-11-16 Neff Thomas B (Chief Executive Officer) Sale 19,318 46.66 901,474
2017-11-15 Kearns Thomas F Jr (Director) Sale 18,000 45.22 813,960
2017-11-15 Kearns Thomas F Jr (Director) Option Ex 18,000 2.35 42,300
2017-11-09 Cotroneo Pat (VP, Finance and CFO) Option Ex 32,407 2.90 93,980
2017-11-06 Yu K Peony (Chief Medical Officer) Sale 7,500 55.53 416,512
2017-10-31 Neff Thomas B (Chief Executive Officer) Sale 19,318 55.93 1,080,513
2017-10-30 Neff Thomas B (Chief Executive Officer) Sale 19,318 56.47 1,090,964
2017-10-17 Neff Thomas B (Chief Executive Officer) Sale 19,318 55.10 1,064,518
2017-10-17 Kurkijarvi Kalevi (Director) Sale 2,000 52.24 104,480
2017-10-16 Neff Thomas B (Chief Executive Officer) Sale 19,318 54.93 1,061,079
2017-10-04 Yu K Peony (Chief Medical Officer) Sale 15,000 60.00 900,000
2017-10-04 Yu K Peony (Chief Medical Officer) Option Ex 15,000 14.57 218,625
2017-10-03 Neff Thomas B (Chief Executive Officer) Sale 19,318 55.77 1,077,364
2017-10-02 Neff Thomas B (Chief Executive Officer) Sale 19,318 54.50 1,052,831
2017-10-02 Yu K Peony (Chief Medical Officer) Sale 40,000 54.40 2,176,000
2017-10-02 Yu K Peony (Chief Medical Officer) Option Ex 30,000 14.57 437,250
2017-09-20 Neff Thomas B (Chief Executive Officer) Sale 19,318 53.59 1,035,155
2017-09-19 Neff Thomas B (Chief Executive Officer) Sale 19,318 53.26 1,028,876
2017-09-18 Kurkijarvi Kalevi (Director) Sale 2,000 52.55 105,100
2017-09-14 Neff Thomas B (Chief Executive Officer) Sale 19,318 51.80 1,000,575
2017-09-14 Yu K Peony (Chief Medical Officer) Sale 2,851 51.00 145,401
2017-09-13 Neff Thomas B (Chief Executive Officer) Sale 19,318 51.40 992,964
2017-09-13 Riggs Rory B (Director) Sale 25,000 51.92 1,298,000
2017-09-11 Cotroneo Pat (VP, Finance and CFO) Sale 2,851 49.45 140,981
2017-09-01 Routti Jorma (Director) Sale 6,000 47.93 287,580
2017-09-01 Routti Jorma (Director) Option Ex 6,000 3.60 21,600
2017-08-31 Routti Jorma (Director) Sale 6,000 46.78 280,680
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of FGEN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Fibrogen Inc (symbol FGEN, CIK number 921299) see the Securities and Exchange Commission (SEC) website.